Cargando…
Molecular and Structural Discrimination of Proline Racemase and Hydroxyproline-2-Epimerase from Nosocomial and Bacterial Pathogens
The first eukaryotic proline racemase (PRAC), isolated from the human Trypanosoma cruzi pathogen, is a validated therapeutic target against Chagas' disease. This essential enzyme is implicated in parasite life cycle and infectivity and its ability to trigger host B-cell nonspecific hypergammagl...
Autores principales: | Goytia, Maira, Chamond, Nathalie, Cosson, Alain, Coatnoan, Nicolas, Hermant, Daniel, Berneman, Armand, Minoprio, Paola |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964878/ https://www.ncbi.nlm.nih.gov/pubmed/17849014 http://dx.doi.org/10.1371/journal.pone.0000885 |
Ejemplares similares
-
Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas’ Disease
por: Berneman, Armand, et al.
Publicado: (2013) -
Prevalence of proline racemase/ hydroxyproline epimerase gene in human brucella isolates in Iran
por: Hashemifar, Iman, et al.
Publicado: (2017) -
Identification and Characterization of Bifunctional Proline Racemase/Hydroxyproline Epimerase from Archaea: Discrimination of Substrates and Molecular Evolution
por: Watanabe, Seiya, et al.
Publicado: (2015) -
Designed mono- and di-covalent inhibitors trap modeled functional motions for Trypanosoma cruzi proline racemase in crystallography
por: Amaral, Patricia de Aguiar, et al.
Publicado: (2018) -
Uncovering a superfamily of nickel-dependent hydroxyacid racemases and epimerases
por: Desguin, Benoît, et al.
Publicado: (2020)